Aurinia Pharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
235.68 |
268.30 |
309.04 |
361.49 |
366.92 |
400.41 |
| Przychód Δ r/r |
0.00% |
13.84% |
15.18% |
16.97% |
1.50% |
9.13% |
| Przychód (min) |
232.69 |
251.96 |
283.69 |
361.10 |
346.75 |
378.41 |
| Przychód (max) |
238.77 |
282.04 |
355.96 |
361.89 |
394.57 |
430.59 |
| EBITDA (średnia) |
-141.29 |
-160.85 |
-185.27 |
-216.72 |
-219.97 |
-240.05 |
| EBIT (średnia) |
-149.27 |
-169.93 |
-195.73 |
-228.96 |
-232.39 |
-253.61 |
| EBIT % |
-63.34% |
-63.34% |
-63.34% |
-63.34% |
-63.34% |
-63.34% |
| Zysk netto (średni) |
6.46 |
94.78 |
106.01 |
126.38 |
114.03 |
133.77 |
| Zysk netto % |
2.74% |
35.33% |
34.30% |
34.96% |
31.08% |
33.41% |
| EPS (średnia) |
0.03 |
0.65 |
0.76 |
0.95 |
0.78 |
0.92 |
| Liczba analityków (Przychody) |
5 |
5 |
7 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
4 |
5 |
6 |
5 |
2 |
1 |
| symbol |
AUPH |
AUPH |
AUPH |
AUPH |
AUPH |
AUPH |